Skip to main content
Loading ResearchHub…
Correction: Real-World Utilization and Initial Experience with Aflibercept-ayyh (PAVBLU®) for Retinal Disorders in United States Retina Practices: A Descriptive Retrospective Analysis - ResearchHub